Founded in 1979, Sanderling Ventures is amongst the oldest and most established North American venture firms focused exclusively on biomedical investing. We invest in therapeutics, medical devices and information health.

Sanderling has consistently high rates of return across multiple vintage years with multiple top quartile funds.

In Canada, Sanderling utilizes Therillia Development Co., a Sanderling portfolio company based in Montreal, to manage the development of therapeutic assets held by other Sanderling portfolio companies. This model of “active management” utilizes the expertise of Therillia’s seasoned drug development team and has been successful in advancing multiple projects in a cost-effective manner.

Address 1

1010 Sherbrooke St. W., Suite 408
Montreal , Qc, Canada

H3A 2R7

In business since


Business places

  • Montreal

Investment places

  • Quebec
  • United States
  • Europe


Pierre Beauparlant
Venture Partner

Tel 5145646474

Michael Dixon
Venture Partner

Tel 5145646474

Robert McNeil
Managing Director

Contact person

Rosa Di Pierro
Executive Coordinator

Tel 514-564-6474 x 225

Investments types

  • Fund of funds

Nature of the financing / Investment activity

  • Development
  • Seed
  • Start-up

Activity sector

  • Life Sciences